Compare
QT Imaging Holdings, Inc. vs Precision Optics Corporation, Inc. vs CapsoVision, Inc vs Escalon Medical Corp
| Latest fiscal year | QT Imaging Holdings, Inc. QTI | Precision Optics Corporation, Inc. POCI | CapsoVision, Inc CV | Escalon Medical Corp ESMC |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-06-30 | 2025-12-31 | 2025-06-30 |
| Revenue | $18.93M | $19.09M | $13.55M | $12.05M |
| Revenue growth (YoY) | +287.9% | -0.1% | +15.3% | +0.5% |
| Gross margin | 45.4% | 17.8% | 52.9% | 45.7% (computed) |
| Operating margin | -23.4% | -29.1% | -188.3% | 1.1% |
| Net margin | -111.4% | -30.3% | -186.8% | 0.9% |
| Net income | -$21.08M | -$5.78M | -$25.32M | $105.5K |
| EPS (Diluted) | -$2.01 | -$0.85 | -$1.03 | $0.00 |
| Operating cash flow | -$8.96M | -$3.55M | -$22.86M | $380.7K |
| Free cash flow | -$9.08M | -$3.77M | -$22.95M | $376.8K |
| Cash & equivalents | $10.41M | $1.77M | n/a | $545.8K |
| Total assets | $23.02M | $19.79M | $18.16M | $4.99M |
| Total liabilities | $16.58M | $7.53M | $4.90M | $3.08M |
| Shareholders' equity | $6.45M | $12.26M | $13.26M | $1.92M |
| Return on year-end equity | -327.1% | -47.2% | -190.9% | 5.5% |
| Shares outstanding | 11.90M | 7.71M | 46.87M | 7.42M |
Revenue, most recent five fiscal years
| Fiscal year | QT Imaging Holdings, Inc. | Precision Optics Corporation, Inc. | CapsoVision, Inc | Escalon Medical Corp |
|---|---|---|---|---|
| Latest | $18.93M Ended 2025-12-31 | $19.09M Ended 2025-06-30 | $13.55M Ended 2025-12-31 | $12.05M Ended 2025-06-30 |
| 1 year earlier | $4.88M Ended 2024-12-31 | $19.10M Ended 2024-06-30 | $11.76M Ended 2024-12-31 | $11.98M Ended 2024-06-30 |
| 2 years earlier | $40.4K Ended 2023-12-31 | $21.04M Ended 2023-06-30 | n/a | $12.18M Ended 2023-06-30 |
| 3 years earlier | n/a | $15.68M Ended 2022-06-30 | n/a | $10.70M Ended 2022-06-30 |
| 4 years earlier | n/a | $10.67M Ended 2021-06-30 | n/a | $10.47M Ended 2021-06-30 |